Previous 10 | Next 10 |
home / stock / snnuf / snnuf news
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has been named the Preferred Sports Medicine Technology Partner of UFC – the world’s premier mixed martial arts organization and one of the foremost global brands in all of sports. Under the t...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announced they have entered into a Master Cooperative Research and Development Agreement (CRADA) with the U.S. Army Institute of Surgical Research (USAISR). This marks the first time that the USAISR has entered into a m...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces full commercial availability of its AETOS Shoulder System in the US, along with 510(k) clearance for its use with ATLASPLAN ◊ 3D Planning Software and Patient Specific Instrumentation for total shou...
Smith+Nephew (LSE: SN, NYSE:SNN), the global medical technology company, announces it will provide a glimpse into the future at AAOS 2024. With a first opportunity to see a forthcoming new feature* for its CORI ◊ Surgical System, this exclusive image-agnostic* robotic-assisted surgical...
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL ◊ AGILI-C ◊ Cartilage Repair Implant alongside the REGENETEN ◊ Bioinductive Implant at the AAOS Annual Meeting, de...
First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant from a recently comp...
2023-11-05 11:11:03 ET Smith & Nephew plc (SNN) Q3 2023 Earnings Conference Call November 2, 2023, 4:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Conference Call Participants Rober...
2023-10-12 16:31:15 ET Summary Smith & Nephew's shares have fallen over 20% this summer, despite ongoing improvements in the company's operations, as ortho stocks have been especially weak. The impact of GLP-1 drugs on the knee replacement market is uncertain; reduced obesity ...
2023-08-04 02:39:09 ET Smith & Nephew plc (SNN) Q2 2023 Earnings Conference Call August 3, 2023 03:30 ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Conference Call Participants Jack Reyno...
2023-05-14 01:05:59 ET Summary Smith & Nephew has caught a 21% bid in the past 6 months despite no major fundamental changes. Long-term data analysis reveals the company's difficulty in turning capital investments into additional market valuation. Shares look to be fairly ...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew Plc Ord Company Name:
SNNUF Stock Symbol:
OTCMKTS Market:
Smith & Nephew Plc Ord Website:
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its new CORIOGRAPH Pre-Operative Planning and Modeling Services, providing an unparalleled, personalized solution for surgeons and patients across partial and total knee arthroplasty procedures. ...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal , 1 that shows a novel mechanism of actio...